A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia

Refractoriness to initial chemotherapy and relapse after remission are the main obstacles to curing T cell acute lymphoblastic leukemia (T-ALL). While tumor heterogeneity has been implicated in treatment failure, the cellular and genetic factors contributing to resistance and relapse remain unknown. Here we linked tumor subpopulations with clinical outcome, created an atlas of healthy pediatric hematopoiesis and applied single-cell multiomic analysis to a diverse cohort of 40 T-ALL cases. We identified a bone marrow progenitor (BMP)-like leukemia subpopulation associated with treatment failure and poor overall survival. The single-cell-derived molecular signature of BMP-like blasts predicted poor outcome across multiple subtypes of T-ALL and revealed that NOTCH1 mutations additively drive T-ALL blasts away from the BMP-like state. Through in silico and in vitro drug screenings, we identified a therapeutic vulnerability of BMP-like blasts to apoptosis-inducing agents including venetoclax. Collectively, our study establishes multiomic signatures for rapid risk stratification and targeted treatment of high-risk T-ALL.

Authors

Institutions

Publication Details

Journal
Nature Cancer
Published
2024-11-25
DOI
https://doi.org/10.1038/s43018-024-00863-5
Citations
20
Primary Topic
Acute Lymphoblastic Leukemia research
Type
article
Field-Weighted Citation Impact
10.86

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia

Gregory M. Chen, Kai Tan, Mignon L. Loh, Brent Lee Wood et al.
20 citations
Nature Cancer
Acute Lymphoblastic Leukemia research
10.86
article

A multiomic atlas identifies a treatment-resistant, bone marrow progenitor-like cell population in T cell acute lymphoblastic leukemia

Gregory M. Chen, Kai Tan, Mignon L. Loh, Brent Lee Wood, Jianzhong Hu, Nancy R. Zhang, Rushabh Mehta, Stephen P. Hunger, Elizabeth A. Raetz, David T. Teachey, Lauren K. Meyer, Gang Wu, Petri Pölönen, Lahari Uppuluri, Wenbao Yu, Rawan Shraim, Haley Newman, Alexander Li, Jacqueline Peng, Anusha Thadi, Yangyang Ding, David B. Frank, Changya Chen, Charles Grenfell Mullighan, Satoshi Yoshimura, David Wei Wu, Yusha Sun, Jun J. Yang, Kimberly P. Dunsmore, Shovik Bandyopadhyay, Stanley Pounds, Ti‐Cheng Chang, Stuart S. Winter, Caroline Diorio, Omar Elghawy, Tiffaney L. Vincent, William L. Carroll, Kathrin M. Bernt, Chia-Hui Chen, Chi-Yun Wu, Meenakshi Devidas, Joseph S. Tumulty, Elizabeth Y. Li, Zhiguo Chen, Alice Wang, Jessica Xu, Tristan Lim, Kyung Jin Ahn, Jonathan Sussman, Jason Xu, Miles Hsu, Damjan Karanfilovski
article en
20 citations

Abstract

Refractoriness to initial chemotherapy and relapse after remission are the main obstacles to curing T cell acute lymphoblastic leukemia (T-ALL). While tumor heterogeneity has been implicated in treatment failure, the cellular and genetic factors contributing to resistance and relapse remain unknown. Here we linked tumor subpopulations with clinical outcome, created an atlas of healthy pediatric hematopoiesis and applied single-cell multiomic analysis to a diverse cohort of 40 T-ALL cases. We identified a bone marrow progenitor (BMP)-like leukemia subpopulation associated with treatment failure and poor overall survival. The single-cell-derived molecular signature of BMP-like blasts predicted poor outcome across multiple subtypes of T-ALL and revealed that NOTCH1 mutations additively drive T-ALL blasts away from the BMP-like state. Through in silico and in vitro drug screenings, we identified a therapeutic vulnerability of BMP-like blasts to apoptosis-inducing agents including venetoclax. Collectively, our study establishes multiomic signatures for rapid risk stratification and targeted treatment of high-risk T-ALL.

Nature CancerVol. 6(1)
Seattle Children's Hospital (US), St. Jude Children's Research Hospital (US), Children's Hospital of Philadelphia (US), Children's Hospital of Los Angeles (US), Chinese Academy of Medical Sciences & Peking Union Medical College (CN), Yale University (US), University of Florida (US), NYU Langone Health (US), University of Virginia Children's Hospital (US), Seattle Children's Hospital (US), Children's Minnesota (US), Institute of Hematology & Blood Diseases Hospital (CN), University of Minnesota Children's Hospital (US), University of Pennsylvania (US)
Pennsylvania Department of Health, Leukemia and Lymphoma Society, St. Baldrick's Foundation, National Institutes of Health, Hyundai Hope On Wheels
Good health and well-being
Openalex Percentile: Top 1%
Acute Lymphoblastic Leukemia research
10.86
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.